Biotechnology

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA Authorizes Another Pfizer, Moderna Covid Booster for 50 and Up

Rebecca Urena03/29/2022

100

The Food and Drug Administration has authorized a fourth Covid vaccine dose for both Pfizer (NYSE: PFE) and Moderna (NASDAQ: PFE), for people 50 years of age and older....

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Requests Emergency Use for Second Covid Booster Shot

Rebecca Urena03/18/2022

110

Moderna (NASDAQ: MRNA) announced Thursday that it is seeking the US Food and Drug Administration’s authorization for a second Covid-19 booster shot for people over the age of 18....

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Reaches Agreement with Kenya to Establish its First mRNA Manufacturing Facility in Africa

Rebecca Urena03/07/202203/07/2022

109

Moderna (NASDAQ: MRNA) announced Monday that it has established a memorandum of understanding with Kenya to build a covid vaccine manufacturing facility in Africa. The company is building the...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Merck sells $952 Million of Covid-19 Treatment Pill in 4Q

Rebecca Urena02/03/2022

143

Merck (NYSE: MRK) sold USD952 Million of molnupiravir, its Covid-19 treatment pill, during the fourth quarter and is set to sell an additional USD5 Billion to USD6 Billion this...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Novavax Seeks Emergency Use Authorization for Covid Vaccine in South Africa

Rebecca Urena01/10/2022

136

Novavax Inc. (NASDAQ: NVAX), along with Serum Institute of India (SII), announced a regulatory submission to the South African Health Products Regulatory Agency (SAHPRA) for emergency use authorization (EUA)...

Biotechnology Healthcare Investing News Market News The Market Buzz

Biogen Shares Soar Following Report Insinuating Samsung Acquisition

Rebecca Urena12/29/2021

113

Biogen Inc. (NASDAQ: BIIB), a multinational biotechnology company, shares spiked after Korea Economic Daily said it was to be sold to Samsung Group. Additionally, the Korean media report cited...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Receives FDA Approval for its Covid-19 Oral Treatment

Rebecca Urena12/22/202112/22/2021

133

Pfizer’s (NYSE: PFE) oral Covid treatment, Paxlovid, was granted emergency authorization by the Food and Drug Administration on Wednesday. This is the first approved antiviral Covid-19 pill for infected...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Biden Administration Secures Millions of Pfizer Covid Treatment Pill Courses

Rebecca Urena11/18/202111/18/2021

196

President Biden expressed Thursday that the government had acquired 10 million treatment courses of Pfizer’s Covid pill. According to Pfizer (NYSE: PFE), the antiviral pill prevents the hospitalization and...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Regeneron CEO Says its Covid Antibody Treatment Protects for up to 8 Months

Rebecca Urena11/08/2021

159

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) says that within its late-stage trial, a single dose of its antibody cocktail decreased the risk of contracting Covid-19 by 81.6%. The company’s shares...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Claims its Covid-19 Oral Treatment Reduces Risks by 89%

Rebecca Urena11/05/2021

177

Pfizer (NYSE: PFE) announced Friday that its new Covid-19 pill, combined with its well-known HIV drug, reduces the risk of hospitalization and death by about 89% within high-risk adults...

FDA Authorizes Another Pfizer, Moderna Covid Booster for 50 and Up

Moderna Requests Emergency Use for Second Covid Booster Shot

Moderna Reaches Agreement with Kenya to Establish its First mRNA Manufacturing Facility in Africa

Merck sells $952 Million of Covid-19 Treatment Pill in 4Q

Novavax Seeks Emergency Use Authorization for Covid Vaccine in South Africa

Biogen Shares Soar Following Report Insinuating Samsung Acquisition

Pfizer Receives FDA Approval for its Covid-19 Oral Treatment

Biden Administration Secures Millions of Pfizer Covid Treatment Pill Courses

Regeneron CEO Says its Covid Antibody Treatment Protects for up to 8 Months

Pfizer Claims its Covid-19 Oral Treatment Reduces Risks by 89%

The Buzz Surrounding First Responder Technologies Inc.

Entertainment One and Alibaba Pictures Announce Joint Production to Bring Peppa Pig to Theaters in China

Zillow adds Canadian listings to online marketplace

Snapchat Shares Tumble Alongside other Social Media Stocks

Uber Enters Agreement to Expand its Business in Italy

CitiGroup Analysts Expect Space Sector to Become $1 Trillion Industry

Latest Tweets